The global benign prostatic hyperplasia devices market is expected to grow at a CAGR of over 22% during the period 2019–2025. The global benign prostatic hyperplasia (BPH) devices market is expected to observe an absolute growth of over 242% during the forecast period. The market is growing due to several factors; however, the growing number of the elderly men population is a primary factor responsible for influencing the growth of the BPH devices market. BPH is one of the most common diseases in men, which generally develops after the age of 40 years, with a prevalence rate of around 8–60% between 40 and 90 years. Moreover, it affects about 70% of US men between the age of 60 and 69 years. Approximately 32 million men worldwide experience mild to severe symptoms of BPH. According to several medical studies, there are more than 50% of men above age 50 diagnosed with an enlarged prostate. Besides, there are 4 million men who suffer from BPH. Hence, the high prevalence among men is a major factor contributing to the demand for advanced medical devices.
Request to Fill The Form To get Sample Copy of This Business Report: https://www.sdki.jp/sample-request-106083
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”
INSIGHTS BY VENDORS
The global BPH devices market is fairly concentrated and is characterized by the presence of established vendors holding the majority of the share. There is a significant number of global as well as regional players offering advanced BPH devices in the market. Teleflex, KARL STORZ, Lumenis, Urologix, and Boston Scientific are the key players in the benign prostatic hyperplasia devices market. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities.
The following factors are likely to contribute to the growth of the benign prostatic hyperplasia devices market during the forecast period:
• Emergence of Innovative BPH Treatment Devices
• Popularity of Robotic-assistance Surgical Techniques
• Growth in Demand for Minimal Invasive Treatment
Request to Fill The Form To get Sample Copy of This Business Report: https://www.sdki.jp/sample-request-106083
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”
Benign Prostatic Hyperplasia Devices Market Segmentation
The benign prostatic hyperplasia devices market research report includes a detailed segmentation by procedure, end-user, geography. The PUL technology segment is growing due to the increasing patient population and the growing adoption of advanced minimally invasive treatment. PUL is an advanced minimally invasive procedure for the treatment of BPH with less complications. As these procedures can be performed under local, spinal, or general anesthesia or in in-office settings or clinics, the technique is grabbing attention among end-users in developed economies, thereby influencing the segment.
In 2019, the hospital end-user was the largest segment in the global benign prostatic hyperplasia devices market. However, the segment is likely to witness the slowest growth during the forecast period due to the change in patients’ preference in terms of treatment. As BPH surgical treatment is witnessing the application of innovative MI devices, BPH surgical care is moving toward out-patient settings. However, the increasing aging population and the growing patient group with BPH have led to high hospitalization rates. Most patients prefer hospitals, especially public ones, as their priority due to the availability of insurance coverage and less out-of-pocket expenses in case of inadequate reimbursement for BPH surgeries. Further, the availability of skilled healthcare professionals with knowledge and expertise in performing both invasive and MI BPH surgeries also attracts more patients to hospitals.
Market Segmentation by Procedure
• PUL
• Laser Therapy
• TURP
• Others
Market Segmentation by End-user
• Hospitals
• Specialty Urology Centers
• Ambulatory Surgery Centers (ASC)
Request to Fill The Form To get Sample Copy of This Business Report: https://www.sdki.jp/sample-request-106083
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”
Table of Content
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Procedure
4.4.2 Market Segmentation by End-User
4.4.3 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
KEY QUESTIONS ANSWERED
1. What is the market size and CAGR of the global benign prostatic hyperplasia (BPH) devices market?
2. What are the factors impacting the Asia Pacific benign prostatic hyperplasia (BPH) devices market growth?
3. What are the drivers, trends, and restraints impacting the Laser Therapy market?
4. Who are the top vendors of the BPH devices market and what are their market shares?
5. Which region/end-user is the largest revenue generating segment in the BPH devices market?
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790
Related Reports:
Cardiac Pacemaker Market
Infertility Treatment Market
Global Geared Motors Market
Oil And Gas Processing Seals Market
Global Marking Materials Market
Pump Market
